1-10 of 10
Aaron Hansen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT250: A first-in-human phase 1 study of NL-201 in patients with relapsed or refractory cancer

Aung Naing, Margaret Callahan, Brian A. Costello, Brendan Curti, Evan Hall, Aaron Hansen, Georgina V. Long, Anthony M. Joshua, Cynthia Wetmore, Andrew Weickhardt
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT250.
DOI: https://doi.org/10.1158/1538-7445.AM2022-CT250
Published: 15 June 2022
View article
Journal Articles

Abstract P154: Genomic profiling and matched therapy for recurrent or metastatic salivary gland neoplasms. Results from the matched cohort of the GEMS-001 clinical trial

Alberto Hernando-Calvo, Eoghan Malone, Daphne Dai, Amy Prawira, Ilan Weinreb, Anneli Eliason, Angela Rodriguez, Katherine Lajkosz, Sarah Jennings, Anna Spreafico, Lillian L. Siu, Aaron Hansen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P154.
DOI: https://doi.org/10.1158/1535-7163.TARG-21-P154
Published: 01 December 2021
View article
Journal Articles

Abstract P239: Safety and efficacy of copanlisib in combination with nivolumab: A phase Ib study in patients with advanced solid tumors

Benedito A. Carneiro, Robert Jotte, Nashat Gabrail, Omid Hamid, Funan Huang, Shalini Chaturvedi, Matthias Herpers, Lidia Mongay Soler, Barrett H. Childs, Aaron Hansen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P239.
DOI: https://doi.org/10.1158/1535-7163.TARG-21-P239
Published: 01 December 2021
View article
Journal Articles

Abstract 26: A novel electronic platform to improve clinical trial workflow and screening

Ramy R. Saleh, Olivia Chan, Silvi Kuld, Patrick Marban, Anna Spreafico, Aaron Hansen, Albiruni Razak, Lillian L. Siu, Philippe L. Bedard
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12_Supplement_1): 26.
DOI: https://doi.org/10.1158/1557-3265.ADVPRECMED20-26
Published: 15 June 2020
View article
Journal Articles

Abstract PD4-02: Canadian cancer trials group trial IND.231: A phase 1 trial evaluating CX-5461, a novel first-in-class G-quadruplex stabilizer in patients with advanced solid tumors enriched for DNA-repair deficiencies

John Hilton, Karen Gelmon, David Cescon, Anna Tinker, Derek Jonker, Rachel Goodwin, Scott Laurie, Aaron Hansen, Samuel Aparicio, John Soong, Linda Hagerman, Hongbo Lui, Philippe Bedard, Kathleen Pritchard, Dongsheng Tu, Lesley Seymour
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD4-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-PD4-02
Published: 15 February 2020
View article
Journal Articles

Abstract CT166: A Phase I/II, open-label, two part study of GSK3359609 in combination with tremelimumab in participants with selected, advanced solid tumors

Aaron Hansen, Raghad Abdul-Karim, Naiyer Rizvi, Danny Rischen, John Hilton, Zujun Li, Patrick Ott, Natalie Karpinich-Fedoriw, Sapna Yadavilli, Xiaowei Wang, Laurel Adams, Melody Wyres, Charles Ferte, Marc Ballas, Axel Hoos, Daniel Zandberg
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT166.
DOI: https://doi.org/10.1158/1538-7445.AM2019-CT166
Published: 01 July 2019
View article
Journal Articles

Abstract CT124: Sitravatinib and nivolumab in oral cavity cancer window of opportunity study (SNOW)

Marc Oliva Bernal, Douglas Chepeha, Amy Prawira, Douglass Vines, Anna Spreafico, Scott Bratman, John De Almeida, Aaron Hansen, David Goldstein, Ralph Gilbert, Patrick Gullane, Dale H. Brown, Ilan Weinreb, Bayardo Perez-Ordoñez, Pamela S. Ohashi, Tracy McGaha, Ben X. Wang, Jonathan Irish, Isan Chen, Lillian L. Siu
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT124.
DOI: https://doi.org/10.1158/1538-7445.AM2019-CT124
Published: 01 July 2019
View article
Journal Articles

Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer

Anuradha Krishnamurthy, Arvind Dasari, Anne M. Noonan, Janice M. Mehnert, Albert C. Lockhart, Stephen Leong, Anna Capasso, Mark N. Stein, Hanna K. Sanoff, James J. Lee, Aaron Hansen, Usha Malhotra, Sarah Rippke, Daniel L. Gustafson, Todd M. Pitts, Kim Ellison, S. Lindsey Davis, Wells A. Messersmith, S. Gail Eckhardt, Christopher H. Lieu
Journal: Cancer Research
Cancer Res (2018) 78 (18): 5398–5407.
DOI: https://doi.org/10.1158/0008-5472.CAN-18-0316
Published: 14 September 2018
View article
PDF
Journal Articles

Abstract CT039: INDUCE-1: a phase I open-label study of GSK3359609, an ICOS agonist antibody, administered alone and in combination with pembrolizumab in patients with selected, advanced solid tumors

Eric Angevin, Todd M. Bauer, Catherine E. Ellis, Hui Gan, Rigel Hall, Aaron Hansen, Axel Hoos, Roxanne C. Jewell, Jessica Katz, Juan Martin-Liberal, Michele Maio, Patrick A. Mayes, Jolly Mazumdar, Michael Millward, Danny Rischin, Jan H. Schellens, Sapna Yadavilli, Helen Zhou
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): CT039.
DOI: https://doi.org/10.1158/1538-7445.AM2017-CT039
Published: 01 July 2017
View article
Journal Articles

Abstract CT146: A phase IB study of the combination of AZD6244 hydrogen sulfate (selumetinib) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC)

Anna Capasso, Arvind Dasari, A. Craig Lockhart, Mark Stein, Hanna Sanoff, James Lee, Aaron Hansen, Tanios Bekaii-Saab, Sarah Rippke, James Yao, Funda Meric-Bernstam, S Gail Eckhardt, Christopher h. Lieu
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): CT146.
DOI: https://doi.org/10.1158/1538-7445.AM2016-CT146
Published: 15 July 2016
View article